HbAl与冠心病患者经皮桡动脉穿刺介入治疗预后的相关性研究.doc

HbAlc与冠心病患者经皮挠动脉穿刺介入治疗预后的相关性研宄 ［ ］目的探?糖化血红蛋白（HbAlc）与冠 心病患者经皮桡动脉穿刺介入治疗预后的相关性。方 法回顾性分析2011年3月?2014年9月我院收治的 237例经皮挠动脉穿刺介入治疗术治疗的冠心病患者 临床病例资料。并按照糖尿病病史及HbAlc水平将其 分为三组：合并糖尿病且HbAlc彡6.5%的冠心病患者 （A组）41例；合并糖尿病且HbAlcO.O5）。随访24 个月时，A组不良心血管事件发生率为36.59%，B组 为25.92%, C组为17.16%，A组和B组的不良心血管 事件发生率明显高于C组，（A组+B组）与C组比较 差异有统计学意义。结论HbAlc与冠心病患者经皮挠 动脉穿刺介入治疗术长期预后有关，临床可通过降低 血糖、有效控制HbAlc水平，改善冠心病患者的长期 预后。 ［关键词］冠心病；糖化血红蛋白；糖尿病；经皮 侥动脉穿刺介入治疗 ［ ］R587.1； R541.4 ［ ］A ［文 章编号］1673-9701 （2017） 10-0016-03 Analysis the relationship between HbAlc and prognosis of patients with coronary heart disease underwent percutaneous transradial intervention DENG Tingting HUA Yongping XI Gang SHI Xiuming ZENG Mansheng Department of Cardiology， the Third People’s Hospital of Jingdezhen in Jiangxi Province，Jingdezhen 333000，China [Abstract] Objective To explore the relevant research of glycosylated hemoglobin (HbAlc) and percutaneous radial artery puncture interventional treatment prognostic for patients with coronary heart disease (CHD) . Methods Retrospective analysis the clinical medical records of 237 patients with coronary heart disease (CHD) from March 2011 to September 2014 in our hospital for the treatment of percutaneous radial artery puncture. And according to the history of diabetes and HbAlc levels divided into three groups： patients of coronary heart disease combine with diabetes and HbAlc^6.5% (group A) were 41 cases； patients of coronary heart disease combine with diabetes and HbAlc0.05) ? Follow-up visit for twenty-four months， the incidence of adverse cardiovascular events of group A was 36.59%， that of group B was 25.92%，that of group C was 17.16%，the incidence of adverse cardiovascular events of group A and group B was significantly higher than that of group C， the difference was statistically significant between the group (A+B) and group C. Conclusion HbAlc is related to the long-term prognosis of patients of coronary heart disease treatment with percutaneous radial artery puncture interventional, which